Didier Vertommen

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B

Ming‐Fei Hsu, B. Viollet, D. Vertommen, 2016, Nature Communications.

Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.

D. Vertommen, E. Schaftingen, M. Veiga-da-Cunha, 2006, Diabetes & metabolism.

Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.

D. Vertommen, C. Proud, M. Rider, 2017, Cellular signalling.

Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis

D. Vertommen, C. Proud, A. Lavoinne, 2002, Current Biology.

How mass spectrometry can be exploited to study AMPK.

Manuel Johanns, Didier Vertommen, Mark H Rider, 2024, Essays in biochemistry.

Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis

M. Rider, S. Horman, C. G. Proud, 2002 .